Advertisement
Research Topics
Subscribe to Research Topics
View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Special Report: Many Stem Cell Clinical Trials for Macular Degeneration

October 31, 2014 11:22 am | by Cynthia Fox, Science Editor | Articles | Comments

The most potent stem cells are coming to patients after helping blind (and nearly blind) mice see for years. Read more...                                                                                

Increased Dosing of Malaria Drug in Children May Lower Infection Risk

October 31, 2014 10:27 am | News | Comments

Piperaquine is a long-acting malaria drug that kills residual parasites and decreases the risk of reinfection. A study led by Uppsala University researcher Martin Bergstrand shows that increasing the dose used in children could potentially decrease the yearly incidence of malaria by 70%. Read more... 

Daiichi Sankyo's Heart Drug Gets FDA Recommendation

October 31, 2014 10:11 am | News | Comments

Daiichi Sankyo announced that the FDA Cardiovascular and Renal Drugs Advisory Committee voted 9 to 1 to recommend approval of once-daily Savaysa (edoxaban) 60 mg dosing regimen for the reduction in risk of stroke and systemic embolic events (SEE) in patients with non-valvular atrial fibrillation (NVAF). Read more...

Advertisement

Profectus BioSciences Gets $9.5M DoD Funding for Ebola/Marburg Vaccine

October 31, 2014 10:00 am | News | Comments

Profectus BioSciences Inc. announced that the DoD through the Medical Countermeasure Systems-Joint Vaccine Acquisition Program (MCS-JVAP), a subordinate command of the Joint Program Executive Office for Chemical and Biological Defense, Edgewood, MD, has contracted the manufacture and IND-enabling preclinical testing of the Profectus trivalent Ebola/Marburg vaccine.  Read more...

Making Lab-Grown Tissues Stronger

October 30, 2014 1:30 pm | News | Comments

Lab-grown tissues could one day provide new treatments for injuries and damage to the joints, including articular cartilage, tendons and ligaments. Read more..                                   

TNIB to Start 90-Day HIV/AIDS Trial in Nigeria

October 30, 2014 1:16 pm | News | Comments

TNI BioTech Inc., a specialty pharmaceutical company involved in the manufacture, distribution and marketing of novel, patented therapies to combat chronic, life-threatening diseases through the activation and modulation of the body's immune system, through its wholly owned subsidiary TNI BioTech International Ltd., announces the initiation of a 90-day bridging trial in Nigeria of Lodonal in patients with HIV/AIDS. Read more...

FDA Approves Generic Alzheimer's Drug

October 30, 2014 12:52 pm | News | Comments

TWi Pharmaceuticals Inc. announced that it has received final approval from the FDA on its Abbreviated New Drug Application (ANDA) for Donepezil Hydrochloride Tablets USP, 23 mg, the generic equivalent to Eisai Inc.'s Aricept 23mg. Read more...     

‘Treasure in Saliva’ May Reveal Diseases Early Enough to Treat

October 30, 2014 12:34 pm | News | Comments

UCLA research could lead to a simple saliva test capable of diagnosing — at an early stage — diabetes and cancer, and perhaps neurological disorders and autoimmune diseases. Read more...

Advertisement

Study Identifies Potential Treatment Target for Cocaine Addiction

October 30, 2014 12:16 pm | News | Comments

A study led by investigators from Massachusetts General Hospital and the Perelman School of Medicine at the University of Pennsylvania has identified a potential target for therapies to treat cocaine addiction. Read more...                        

AstraZeneca's Diabetes Treatment Gets FDA Approval

October 30, 2014 12:00 pm | News | Comments

AstraZeneca announced that the FDA has approved once-daily Xigduo XR (dapagliflozin and metformin hydrochloride extended-release) for the treatment of adults with type 2 diabetes. Read more...                 

Body Clock Gene May Impact Drug Delivery

October 30, 2014 10:32 am | News | Comments

A new effort mapping 24-hour patterns of expression for thousands of genes in 12 different mouse organs provides important clues about how the role of timing may influence the way drugs work in the body. Read more...        

Research Reveals Fish Are Smarter Than We Thought

October 30, 2014 10:08 am | News | Comments

The discovery could pave the way for new medical advances in stroke rehabilitation and in treatments for attention deficit disorders. Read more...                        

NeuroDerm Announces Positive Phase 2 Results of Parkinsons Vaccine

October 30, 2014 9:49 am | News | Comments

NeuroDerm announced positive phase 2 results for a new Parkinsons vaccine. Read more...                             

Advertisement

Scientists Aim to Simplify Life Saving Drug

October 30, 2014 9:33 am | News | Comments

A research team from the University of British Columbia has set out to make the use of Heparin a lot safer by developing a universal antidote. Read more...                

Pfizer Gains FDA Approval for Meningococcal B Vaccine

October 30, 2014 9:14 am | News | Comments

Pfizer announced that the FDA has granted accelerated approval of a new meningococcal vaccine. Read more...                          

Google Developing Pill to Detect Cancer

October 29, 2014 12:46 pm | by Brandon Bailey - AP Technology Writer - Associated Press | News | Comments

Google is working on a cancer-detecting pill in its latest effort to push the boundaries of technology. Read more...                                          

Where's the Czar? Ebola Raises Management Questions

October 29, 2014 12:40 pm | by Jim Kuhnhenn - Associated Press | News | Comments

Obama is pressing to dispel criticism that the government can't manage the Ebola crisis. Read more...                           

Generic Meds Boost Adherence to Breast Cancer Therapy

October 29, 2014 12:30 pm | News | Comments

 A study by Columbia University Medical Center researchers has found that the introduction of generic aromatase inhibitors increased cancer treatment adherence. Read more...             

ESMO: Cancer Immunotherapy on the Road

October 29, 2014 12:20 pm | by Neil Canavan | Articles | Comments

Since cancer immunotherapy was declared the Breakthrough of the Year in 2013 by Science magazine the field has been on fire, and its relatively few experts have been on the run– explaining the nascent technology and related data to oncologists at venues from the April meeting of AACR in San Diego, to the June meeting of ASCO in Chicago, to the September meeting of ESMO in Madrid.  Read more...

Scientists Uncover Major Factor in Development of Huntington's

October 29, 2014 12:16 pm | News | Comments

Scientists from The Scripps Research Institute have uncovered a major contributor to Huntington’s disease. Read more...                        

Pfizer's Antidepressant May Not Affect Sexual Function

October 29, 2014 10:19 am | News | Comments

Pfizer Inc. announced the publication of a clinical study in the Journal of Clinical Psychiatry showing comparable sexual function in adult patients diagnosed with major depressive disorder (MDD) treated daily with Pristiq Extended Release Tablets 50mg and 100mg doses versus placebo. Read more...

Genetic Link to Kidney Stones Identified

October 29, 2014 10:14 am | News | Comments

A new breakthrough could help kidney stone sufferers get an exact diagnosis and specific treatment after genetic links to the condition were identified. Read more...                

Boehringer Ingelheim, Lilly Restructure Diabetes Alliance

October 29, 2014 10:01 am | News | Comments

In a move that will strengthen their alliance by enhancing efficiencies and enabling greater focus on product launches, Boehringer Ingelheim and Eli Lilly and Company are changing the operational and financial structure of their diabetes alliance in certain countries. Read more...

Blood Test May Diagnose Early Onset Alzheimer's

October 29, 2014 9:52 am | News | Comments

A non-invasive blood test that could diagnose early onset Alzheimer’s disease with increased accuracy. Read more...                        

Boehringer Ingelheim Present Data on COPD Drug

October 28, 2014 1:22 pm | News | Comments

Boehringer Ingelheim presented data from the ANHELTO 1&2 studies that evaluated the co-administration of Spiriva HandiHaler plus Striverdi Respimat Inhalation Spray inhaler in patients with COPD. Read more...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading